» Articles » PMID: 2651179

Basic Fibroblast Growth Factor Promotes the Survival and Development of Mesencephalic Neurons in Culture

Overview
Journal Dev Biol
Publisher Elsevier
Date 1989 May 1
PMID 2651179
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Neuronotrophic effects of basic fibroblast growth factor (bFGF) have been reported for some central nervous system neurons. Here we report that also rat mesencephalic neurons are responsive to bFGF. bFGF produces a significant increase in the number of neurite-bearing cells, as well as in the degree of their fiber network. The present findings also provide the first evidence that bFGF can affect, in a concentration-dependent manner, at least two defined CNS neuronal populations, i.e., dopaminergic and gabaergic neurons. This effect was quantified by assessing the specific [3H]dopamine and [gamma-14C]aminobutyric acid uptakes with time in culture. Stimulation of uptake was more pronounced for dopaminergic neurons, suggesting a relative specificity in the actions of bFGF. These effects of bFGF were completely blocked by affinity-purified polyclonal antibodies. The possibility that bFGF plays a key role in normal nervous system development or function is discussed.

Citing Articles

Effects of Passage Number and Differentiation Protocol on the Generation of Dopaminergic Neurons from Rat Bone Marrow-Derived Mesenchymal Stem Cells.

Shall G, Menosky M, Decker S, Nethala P, Welchko R, Leveque X Int J Mol Sci. 2018; 19(3).

PMID: 29498713 PMC: 5877581. DOI: 10.3390/ijms19030720.


Establishment of a survival and toxic cellular model for Parkinson's disease from chicken mesencephalon.

Tolosa A, Zhou X, Spittau B, Krieglstein K Neurotox Res. 2012; 24(2):119-29.

PMID: 23238634 PMC: 3691473. DOI: 10.1007/s12640-012-9367-y.


Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.

Salti A, Nat R, Neto S, Puschban Z, Wenning G, Dechant G Stem Cells Dev. 2012; 22(3):397-411.

PMID: 22889265 PMC: 3549628. DOI: 10.1089/scd.2012.0238.


Pathways towards an effective immunotherapy for Parkinson's disease.

Hutter-Saunders J, Mosley R, Gendelman H Expert Rev Neurother. 2011; 11(12):1703-15.

PMID: 22091596 PMC: 3263336. DOI: 10.1586/ern.11.163.


Strain difference in the up-regulation of FGF-2 protein following a neurotoxic lesion of the nigrostriatal pathway.

Yurek D, Fletcher A, Peters L, Cass W Neurochem Res. 2009; 35(4):531-9.

PMID: 19921430 PMC: 3032212. DOI: 10.1007/s11064-009-0093-7.